Cancer Journal

Papers
(The H4-Index of Cancer Journal is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Epidemiology of Triple-Negative Breast Cancer155
Immunotherapy in Triple-Negative Breast Cancer42
Adjuvant and Neoadjuvant Treatment of Triple-Negative Breast Cancer With Chemotherapy37
Menopausal Hormone Replacement Therapy and Reduction of All-Cause Mortality and Cardiovascular Disease34
Menin Inhibitors in Acute Myeloid Leukemia—What Does the Future Hold?34
Cytokine Release Syndrome Biology and Management31
PARP Inhibitors in Pancreatic Cancer23
Immunotherapy in EGFR-Mutant and ALK-Positive Lung Cancer21
Challenges and Errors in Genetic Testing16
Triple-Negative Breast Cancer15
Obesity and Energy Balance Considerations in Triple-Negative Breast Cancer14
Development of Next-Generation Poly(ADP-Ribose) Polymerase 1–Selective Inhibitors14
Tumor-Infiltrating Lymphocyctes in Triple-Negative Breast Cancer13
How We Incorporate Venetoclax in Treatment Regimens for Acute Myeloid Leukemia13
Immunotherapy Use in Patients With Lung Cancer and Comorbidities13
0.037445068359375